The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer

Autophagy

Volumn 12, Issue 5, 2016, Pages 864-875

  Ladoire, Sylvain ^a,b,c   Enot, David ^d   Senovilla, Laura ^c,e,f,g   Ghiringhelli, François ^a,b   Poirier Colame, Vichnou ^c   Chaba, Kariman ^c,e,f   Semeraro, Michaela ^c,g,h   Chaix, Marie ^a,b   Penault Llorca, Frédérique ^i,j   Arnould, Laurent ^a   Poillot, Marie Laure ^k   Arveux, Patrick ^k   Delaloge, Suzette ^d   Andre, Fabrice ^d   Zitvogel, Laurence ^c,g,h   Kroemer, Guido ^c,d,e,f,l,m  

^a Georges François Leclerc Center   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c INSERM   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h Center of Clinical Investigations in Biotherapies of Cancer   (France)

ⁱ Center Jean Perrin   (France)

^j UNIVERSITÉ CLERMONT AUVERGNE   (France)

^k CENTRE GEORGES FRANÇOIS LECLERC   (France)

^l HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^m KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

autophagy; breast cancer; CD8; histology; HMGB1; LC3; lymphocytes; macrophages; pathology; prognostic; Treg cells

Indexed keywords

CD68 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3 BETA; PROTEIN; PROTEIN SQSTM1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HMGB1 PROTEIN, HUMAN; MAP1LC3B PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL NUCLEUS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; BREAST TUMOR; FEMALE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

AUTOPHAGY; BREAST NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HMGB1 PROTEIN; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84971517378     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2016.1154244     Document Type: Article

References (45)

1. L.Galluzzi, F.Pietrocola, J.M.Bravo-San Pedro, R.K.Amaravadi, E.H.Baehrecke, F.Cecconi, P.Codogno, J.Debnath, D.A.Gewirtz, V.Karantza, et al. Autophagy in malignant transformation and cancer progression. EMBO J 2015; 34:856-80; PMID:25712477; http://dx.doi.org/10.15252/embj.201490784
2. X.H.Liang, S.Jackson, M.Seaman, K.Brown, B.Kempkes, H.Hibshoosh, B.Levine. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-6; PMID:10604474; http://dx.doi.org/10.1038/45257
3. H.Tang, S.Sebti, R.Titone, Y.Zhou, C.Isidoro, T.S.Ross, H.Hibshoosh, G.Xiao, M.Packer, Y.Xie, et al. Decreased mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis. EBioMedicine 2015; 2:255-63; PMID:25825707; http://dx.doi.org/10.1016/j.ebiom.2015.01.008
4. X.Qu, J.Yu, G.Bhagat, N.Furuya, H.Hibshoosh, A.Troxel, J.Rosen, E.L.Eskelinen, N.Mizushima, Y.Ohsumi, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809-20; PMID:14638851; http://dx.doi.org/10.1172/JCI20039
5. M.Cicchini, R.Chakrabarti, S.Kongara, S.Price, R.Nahar, F.Lozy, H.Zhong, A.Vazquez, Y.Kang, V.Karantza. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy 2014; 10:2036-52; PMID:25483966; http://dx.doi.org/10.4161/auto.34398
6. L.Wang, L.Yao, Y.Z.Zheng, Q.Xu, X.P.Liu, X.Hu, P.Wang, Z.M.Shao. Expression of autophagy-related proteins ATG5 and FIP200 predicts favorable disease-free survival in patients with breast cancer. Biochem Biophys Res Commun 2015; 458:816-22; PMID:25689718; http://dx.doi.org/10.1016/j.bbrc.2015.02.037
7. Y.He, X.Zhao, N.R.Subahan, L.Fan, J.Gao, H.Chen. The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis. Tumour Biol 2014; 35:7317-26; PMID:24838948; http://dx.doi.org/10.1007/s13277-014-2060-4
8. S.Ladoire, F.Penault-Llorca, L.Senovilla, C.Dalban, D.Enot, C.Locher, N.Prada, V.Poirier-Colame, K.Chaba, L.Arnould, et al. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy 2015; 11:1878-90; PMID:26506894; http://dx.doi.org/10.1080/15548627.2015.1082022
9. L.Galluzzi, F.Pietrocola, B.Levine, G.Kroemer. Metabolic control of autophagy. Cell 2014; 159:1263-76; PMID:25480292; http://dx.doi.org/10.1016/j.cell.2014.11.006
10. B.Levine, N.Mizushima, H.W.Virgin. Autophagy in immunity and inflammation. Nature 2011; 469:323-35; PMID:21248839; http://dx.doi.org/10.1038/nature09782
11. V.Karantza-Wadsworth, S.Patel, O.Kravchuk, G.Chen, R.Mathew, S.Jin, E.White. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21:1621-35; PMID:17606641; http://dx.doi.org/10.1101/gad.1565707
12. D.R.Green, L.Galluzzi, G.Kroemer. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333:1109-12; PMID:21868666; http://dx.doi.org/10.1126/science.1201940
13. M.Elgendy, C.Sheridan, G.Brumatti, S.J.Martin. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 2011; 42:23-35; PMID:21353614; http://dx.doi.org/10.1016/j.molcel.2011.02.009
14. D.J.Goussetis, E.Gounaris, E.J.Wu, E.Vakana, B.Sharma, M.Bogyo, J.K.Altman, L.C.Platanias. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. Blood 2012; 120:3555-62; PMID:22898604; http://dx.doi.org/10.1182/blood-2012-01-402578
15. H.Vakifahmetoglu-Norberg, M.Kim, H.G.Xia, M.P.Iwanicki, D.Ofengeim, J.L.Coloff, L.Pan, T.A.Ince, G.Kroemer, J.S.Brugge, et al. Chaperone-mediated autophagy degrades mutant p53. Genes Dev 2013; 27:1718-30; PMID:23913924; http://dx.doi.org/10.1101/gad.220897.113
16. Y.Ma, S.Adjemian, S.R.Mattarollo, T.Yamazaki, L.Aymeric, H.Yang, J.P.Portela Catani, D.Hannani, H.Duret, K.Steegh, et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 2013; 38:729-41; PMID:23562161; http://dx.doi.org/10.1016/j.immuni.2013.03.003
17. S.Rao, L.Tortola, T.Perlot, G.Wirnsberger, M.Novatchkova, R.Nitsch, P.Sykacek, L.Frank, D.Schramek, V.Komnenovic, et al. A dual role for autophagy in a murine model of lung cancer. Nat Commun 2014; 5:3056; PMID:24445999; http://dx.doi.org/10.1038/ncomms4056
18. M.Michaud, I.Martins, A.Q.Sukkurwala, S.Adjemian, Y.Ma, P.Pellegatti, S.Shen, O.Kepp, M.Scoazec, G.Mignot, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334:1573-7; PMID:22174255; http://dx.doi.org/10.1126/science.1208347
19. M.Michaud, X.Xie, J.M.Bravo-San Pedro, L.Zitvogel, E.White, G.Kroemer. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology 2014; 3:e944047; PMID:25610726; http://dx.doi.org/10.4161/21624011.2014.944047
20. A.Ko, A.Kanehisa, I.Martins, L.Senovilla, C.Chargari, D.Dugue, G.Marino, O.Kepp, M.Michaud, J.L.Perfettini, et al. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ 2014; 21:92-9; PMID:24037090; http://dx.doi.org/10.1038/cdd.2013.124
21. C.Denkert, S.Loibl, A.Noske, M.Roller, B.M.Muller, M.Komor, J.Budczies, S.Darb-Esfahani, R.Kronenwett, C.Hanusch, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010; 28:105-13; PMID:19917869; http://dx.doi.org/10.1200/JCO.2009.23.7370
22. S.Loi, N.Sirtaine, F.Piette, R.Salgado, G.Viale, F.Van Eenoo, G.Rouas, P.Francis, J.P.Crown, E.Hitre, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. J Clin Oncol 2013; 31:860-7; PMID:23341518; http://dx.doi.org/10.1200/JCO.2011.41.0902
23. G.Stoll, D.Enot, B.Mlecnik, J.Galon, L.Zitvogel, G.Kroemer. Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy. Oncoimmunology 2014; 3:e27884; PMID:24790795; http://dx.doi.org/10.4161/onci.27884
24. S.Adams, R.J.Gray, S.Demaria, L.Goldstein, E.A.Perez, L.N.Shulman, S.Martino, M.Wang, V.E.Jones, T.J.Saphner, et al. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 2014; 32:2959-66; PMID:25071121; http://dx.doi.org/10.1200/JCO.2013.55.0491
25. S.Ladoire, L.Arnould, L.Apetoh, B.Coudert, F.Martin, B.Chauffert, P.Fumoleau, F.Ghiringhelli. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clin Cancer Res 2008; 14:2413-20; PMID:18413832; http://dx.doi.org/10.1158/1078-0432.CCR-07-4491
26. S.Ladoire, G.Mignot, S.Dabakuyo, L.Arnould, L.Apetoh, C.Rebe, B.Coudert, F.Martin, M.H.Bizollon, A.Vanoli, et al. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. J Pathol 2011; 224:389-400; PMID:21437909; http://dx.doi.org/10.1002/path.2866
27. D.G.DeNardo, D.J.Brennan, E.Rexhepaj, B.Ruffell, S.L.Shiao, S.F.Madden, W.M.Gallagher, N.Wadhwani, S.D.Keil, S.A.Junaid, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 2011; 1:54-67; PMID:22039576; http://dx.doi.org/10.1158/2159-8274.CD-10-0028
28. B.Ruffell, A.Au, H.S.Rugo, L.J.Esserman, E.S.Hwang, L.M.Coussens. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A 2012; 109:2796-801; PMID:21825174; http://dx.doi.org/10.1073/pnas.1104303108
29. L.Senovilla, I.Vitale, I.Martins, M.Tailler, C.Pailleret, M.Michaud, L.Galluzzi, S.Adjemian, O.Kepp, M.Niso-Santano, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012; 337:1678-84; PMID:23019653; http://dx.doi.org/10.1126/science.1224922
30. M.Miyashita, H.Sasano, K.Tamaki, M.Chan, H.Hirakawa, A.Suzuki, H.Tada, G.Watanabe, N.Nemoto, S.Nakagawa, et al. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2014; 148:525-34; PMID:25395319; http://dx.doi.org/10.1007/s10549-014-3197-y
31. G.Kroemer, L.Senovilla, L.Galluzzi, F.Andre, L.Zitvogel. Natural and therapy-induced immunosurveillance in breast cancer. Nat Med 2015; In Press; PMID:26444637
32. G.Stoll, G.Bindea, B.Mlecnik, J.Galon, L.Zitvogel, G.Kroemer. Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies. Oncotarget 2015; 6:11894-909; PMID:26059437; http://dx.doi.org/10.18632/oncotarget.4180
33. M.V.Dieci, C.Criscitiello, A.Goubar, G.Viale, P.Conte, V.Guarneri, G.Ficarra, M.C.Mathieu, S.Delaloge, G.Curigliano, et al. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol 2015; 26:1518; PMID:26109735; http://dx.doi.org/10.1093/annonc/mdv239
34. M.V.Dieci, M.C.Mathieu, V.Guarneri, P.Conte, S.Delaloge, F.Andre, A.Goubar. Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials. Ann Oncol 2015; 26:1698-704; PMID:25995301; http://dx.doi.org/10.1093/annonc/mdv239
35. G.Stoll, L.Zitvogel, G.Kroemer. Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: a microarray-based meta-analysis. Oncoimmunology 2015; In Press.
36. D.V.Krysko, A.D.Garg, A.Kaczmarek, O.Krysko, P.Agostinis, P.Vandenabeele. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 2012; 12:860-75; PMID:23151605; http://dx.doi.org/10.1038/nrc3380
37. G.Kroemer, L.Galluzzi, O.Kepp, L.Zitvogel. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008
38. R.D.Schreiber, L.J.Old, M.J.Smyth. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486
39. I.Martins, Y.Wang, M.Michaud, Y.Ma, A.Q.Sukkurwala, S.Shen, O.Kepp, D.Metivier, L.Galluzzi, J.L.Perfettini, et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ 2014; 21:79-91; PMID:23852373; http://dx.doi.org/10.1038/cdd.2013.75
40. S.Rao, H.Yang, J.M.Penninger, G.Kroemer. Autophagy in non-small cell lung carcinogenesis: A positive regulator of antitumor immunosurveillance. Autophagy 2014; 10:529-31; PMID:24413089; http://dx.doi.org/10.4161/auto.27643
41. L.Apetoh, F.Ghiringhelli, A.Tesniere, M.Obeid, C.Ortiz, A.Criollo, G.Mignot, M.C.Maiuri, E.Ullrich, P.Saulnier, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622
42. T.Yamazaki, D.Hannani, V.Poirier-Colame, S.Ladoire, C.Locher, A.Sistigu, N.Prada, S.Adjemian, J.P.Catani, M.Freudenberg, et al. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists. Cell Death Differ 2014; 21:69-78; PMID:23811849; http://dx.doi.org/10.1038/cdd.2013.72
43. E.Vacchelli, Y.Ma, E.E.Baracco, A.Sistigu, D.P.Enot, F.Pietrocola, H.Yang, S.Adjemian, K.Chaba, M.Semeraro, et al. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science 2015; 350:972-8; PMID:26516201; http://dx.doi.org/10.1126/science.aad0779
44. S.Ladoire, K.Chaba, I.Martins, A.Q.Sukkurwala, S.Adjemian, M.Michaud, V.Poirier-Colame, F.Andreiuolo, L.Galluzzi, E.White, et al. Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy 2012; 8:1175-84; PMID:22647537; http://dx.doi.org/10.4161/auto.20353
45. T.Hothorn, B.Lausen. On the exact distribution of maximally selected rank statistics. Computational Statistics & Data Analysis 2003; 43:121-37; http://dx.doi.org/10.1016/S0167-9473(02)00225-6